The aim of this meta-analysis was to compare long-term outcomes after myectomy and alcohol septal ablation (ASA) in patients with hypertrophic cardiomyopathy (HCM).
I
n patients with obstructive hypertrophic cardiomyopathy (HCM) who remain highly symptomatic despite optimal medical therapy, septal reduction therapy should be considered. This can be done by either surgical myectomy or alcohol septal ablation (ASA) (1) (2) (3) . Myectomy has been used for more than 5 decades (4). ASA was developed as a percutaneous alternative and was quickly adopted all over the world. Now, 20 years after its introduction, the debate about the safety of ASA continues, especially concerning the arrhythmogenic effect of the ablation scar in patients already at an increased risk of life-threatening arrhythmias. The 2 most recent meta-analyses date back to 2010 and only evaluated short-term outcomes (5, 6) . The aim of this meta-analysis was to compare long-term outcomes after myectomy and ASA. were applied by 2 independent reviewers. Because of our primary interest in long-term outcomes, a minimal mean follow-up was set at 3 years. Observational studies were included, in lack of randomized, controlled trials. STATISTICAL ANALYSIS. Descriptive statistics of patients before the intervention are weighted medians and interquartile ranges. SEs for the differences in weighted medians between the ASA and myectomy group were estimated by 10,000 bootstraps of the weighted-median differences. p Values for the pooled incidence rate differences and weighted medians were calculated using the Wald test. Random-effects meta-analysis was conducted using "metan" func- 
Meta-Analysis of Septal Reduction Therapy for HOCM studies was estimated by the chi-square test and I 2 statistics. Potential sources of heterogeneity were explored by meta-regression analysis, using "metareg" function in Stata. In all analyses, a p value <0.05 was considered significant.
RESULTS
SYSTEMATIC REVIEW. The search strategy retrieved 2,918 references. After eliminating double hits, a total of 1,317 unique references remained ( Figure 1) . After applying the pre-determined inclusion and exclusion criteria during the initial review, a total of 50 studies were selected for further evaluation. Twenty-two studies were subsequently excluded because of overlapping study periods with cohorts containing more patient-years of follow-up . For the same reason, only the ASA cohort from the study by Sorajja et al. (29) was included. A study (30) Twenty-four studies were selected for inclusion, containing 11 ASA cohorts (29, (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) and 16 myectomy cohorts (40, 41, (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) LONG-TERM OUTCOMES. Long-term outcomes per study are shown in Table 2 . In the myectomy cohorts, there were 302 all-cause deaths during follow-up (i.e., Meta-regression showed that ASA cohorts with older patients had higher all-cause mortality rates (p ¼ 0.02); hence, age explained some of the heterogeneity in this group (I 2 residual ¼ 28%, p for heterogeneity ¼ 0.19) (Online Figure 1) . None of the remaining study-level covariates depicted in Table 1 showed a significant association with mortality across the ASA cohorts, nor were there any of the investigated covariates significantly related to mortality across myectomy cohorts.
The rate of (aborted) SCD during long-term follow- When appropriate ICD shocks were excluded from the (aborted) SCD endpoint, the event rates were 0.34%
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DISCUSSION
This is the first systematic review that considers the long-term outcomes after ASA and surgical myectomy. The most important finding of this analysis is that after ASA and myectomy, both mortality and SCD risk are similarly low. Furthermore, we found that patients who undergo ASA have a significantly higher Values are n unless otherwise indicated. *p value for difference between ASA and myectomy groups.
ASCD ¼ aborted sudden cardiac death; SCD ¼ sudden cardiac death; other abbreviations as in Table 1 .
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Meta-Analysis of Septal Reduction Therapy for HOCM Patients who undergo ASA have a higher risk of permanent pacemaker implantation and need for additional septal reduction therapy, which is why myectomy might be more suitable for younger patients.
TRANSLATIONAL OUTLOOK: Studies with long-term followup of HCM patients undergoing myectomy or ASA using newer surgical and interventional techniques are warranted to give better insight into whether these developments actually improve the efficacy and safety of these procedures. Meta-Analysis of Septal Reduction Therapy for HOCM
